Neogen (NEOG) director granted 50,814 options, 19,769 RSUs on Oct 23, 2025
Neogen (NEOG) reported an insider equity grant by a director on 10/23/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Neogen (NEOG) reported an insider equity grant by a director on 10/23/2025. The filing shows 50,814 stock options with a $6.07 exercise price expiring on 10/23/2035, and 19,769 shares acquired.
Per the footnote, the options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants. Following these transactions, the director beneficially owned 112,314 shares, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (Right to Buy) | 50,814 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 19,769 | $6.07 | $120K |
Footnotes (1)
- F1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NEOG’s director report on Form 4 dated 10/23/2025?
What is the exercise price and term of the NEOG options?
What is the vesting schedule for the NEOG equity awards?
What was the ownership form reported for NEOG holdings?
Was the Form 4 filed by one or multiple reporting persons for NEOG?
AI-generated analysis. How Rhea-AI works. Not financial advice.